Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes

Use of high-dose, post-transplant cyclophosphamide (PTCy) results in low rates of graft-versus-host-disease (GVHD) and favorable immune reconstitution, although with higher rates of relapse and somewhat high rates of graft failure. We hypothesized that permissible dose reduction of PTCy might be fea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Wang, Yu, Chang, Ying-Jun, Chen, Lu, Xu, Lan-Ping, Bian, Zhi-Lei, Zhang, Xiao-Hui, Yan, Chen-Hua, Liu, Kai-Yan, Huang, Xiao-Jun
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5674947/
https://ncbi.nlm.nih.gov/pubmed/29147612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1356152
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars